Quesada VV, Vargas NF, Piedra CW

Language: Spanish
References: 16
Page: 1-8
PDF size: 323.03 Kb.

ABSTRACT

Achalasia is an uncommon disorder of the esophageal motility, with an incidence that varies from 1 to 10 cases per 100.000 patients. Its pathophysiology, that is not completely described, however is based in a process of inflammation, fibrosis and destruction of the myenteric plexus that carries to the symptoms of the disease. For the diagnostic many techniques are useful, being the esophageal manometry the gold standard. In the treatment of this entity has been used multiple techniques, that goes from medical treatment to invasive techniques like surgical myotomy. In recent years, the importance of the use of endoscopic techniques such as POEM has gained importance, which is a minimally invasive procedure with which it is possible to perform the myotomy of the EEI, without the need to access the mediastinum, which has generated a decrease in complications with an adequate resolution of patient symptoms.

REFERENCES

1. Patel D Lappas B Vaezi M. An Overview of Achalasia and Its Subtypes. Gastroenterology & Hepatology. 2017; 13 (7): 411-421

2. Pressman A Behar J. Etiology and Pathogenesis of Idiopathic Achalasia. J Clin Gastroenterol. 2017; 51 (3): 195-202

3. Stavropoulos S Friedel D Modayil R Parkman H. Diagnosis and management of esophageal achalasia. BMJ 2016; 353: 1-18

4. Smith S Louie B. The current state of per oral endoscopic myotomy for achalasia. Journal of Visualized Surgery 2017; 3:122

5. Roushan N Zolfaghari A Asadi M Taslimi R. Pseudoachalasia: a diagnostic challenge. Medical Journal of the Islamic Republic of Iran. 2014; 28 (54): 1-4.

6. Furuzawa-Carballeda J Torres-Landa S Valdovinos M Coss-Adame E Martín del Campo L Torres-Villalobos G. New insights into the pathophysiology of achalasia and implications for future treatment. World Journal of Gastroenterology. 2016; 22(35): 7892-7907

7. Vaezi M Pandolfino J Vela M. ACG Clinical Guideline: Diagnosis and Management of Achalasia. Am J Gastroenterol. 2013; 108 (8):1238-49

8. Krill J Naik R Vaezi M. Clinical management of achalasia: current state of the art. Clinical and Experimental Gastroenterology. 2016; 9: 71–82

9. Mikaeli J Veisari AK Fazlollahi N et al. Ethanolamine oleate versus botulinum toxin in the treatment of idiopathic achalasia. Annals of Gastroenterology. 2015; 28: 229-235

10. Farell-Rivas J, Soto-Pérez JC, Mata-Quintero CJ, et al. Manejo endoscópico de la acalasia: revisión clínica. Endoscopia. 2014; 26(3): 95-103

11. Stavropoulos S Friedel D Modayil R Iqbal S Grendell J. Endoscopic approaches to treatment of achalasia. Therapeutic Advances in Gastroenterology. 2013; 6(2): 115–135

12. Ortega JA Madureri V Perez L. Endoscopic myotomy in the treatment of achalasia. Gastrointest Endosc. 1980; 26(1): 8–10.

13. Pasricha PJ Hawari R Ahmed I et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy. 2007; 39(9):761–764.

14. Inoue H Minami H Kobayashi Y et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010; 42(4): 265–271.

15. Ngamruengphong S Inoue H Wai-Yan P et al. Long-term outcomes of per-oral endoscopic myotomy in patients with achalasia with a minimum follow-up of 2 years: an international multicenter study. Gastrointestinal Endoscopy Journal. 2017; 85 (5): 927-933

16. Boeckxstaens GE Annese V des Varannes SB et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011; 364: 1807-1816.